As a core thrombolytic drug in global cardiovascular healthcare, Urokinase
plays an irreplaceable role in treating acute thrombotic diseases such as
myocardial infarction, cerebral infarction and pulmonary embolism. By activating
the fibrinolytic system to dissolve intravascular thrombi and restore blood flow
patency, it has become a first-line medication for saving the lives of patients
with acute thrombosis. With the global incidence of cardiovascular diseases on
the rise—there are over 500 million patients worldwide—the demand for
high-quality Urokinase continues to surge. For medical institutions,
pharmaceutical distributors and procurement teams, partnering with a reliable
Urokinase manufacturer is critical to ensuring medication safety, clinical
efficacy and stable supply. Kangyuan, a professional pharmaceutical enterprise
committed to high-standard drug production, has established a strong presence in
the global market by adhering to strict quality management and technological
innovation.
The core competitiveness of a high-quality Urokinase manufacturer lies in
strict compliance with GMP standards and full-process quality control. As a
biochemical drug with high clinical safety requirements, Urokinase production
must meet rigorous norms from raw material selection to finished product
testing. A qualified Urokinase manufacturer should first implement traceable raw
material management, ensuring raw material safety and pollution-free sources.
During production, advanced extraction and purification technologies—such as
microbial fermentation that replaces traditional human urine extraction—are
adopted to improve product purity and yield while reducing production costs.
Additionally, strict virus inactivation and activity detection procedures are
essential to ensure Urokinase’s thrombolytic activity and avoid potential safety
risks. Kangyuan has built a comprehensive quality control system covering raw
material inspection, process monitoring and finished product testing, fully
complying with the 2010 revised Good Manufacturing Practice for Drugs and
international pharmaceutical regulations.
Against the backdrop of the growing global Urokinase market, a reliable
Urokinase manufacturer must also have efficient supply chain capabilities and
market insight. According to market research, the global Urokinase market size
was approximately 520 million US dollars in 2024 and is expected to reach 673
million US dollars by 2031, with a stable compound annual growth rate. Emerging
markets such as Southeast Asia and India have become new growth engines due to
increasing medical demand and population aging. Kangyuan focuses on optimizing
global supply chain management, ensuring timely delivery of Urokinase products
to meet the diverse needs of partners in different regions. By keeping pace with
technological innovation trends, the company continuously optimizes the
lyophilization process to enhance product stability and extend shelf life,
providing strong support for clinical application worldwide.
In the field of cardiovascular healthcare where life-saving is paramount,
the choice of Urokinase manufacturer directly affects clinical treatment effects
and patient trust. Kangyuan, as a trusted Urokinase manufacturer, adheres to the
concept of "quality first, patient-centered" and is committed to providing
high-purity, high-activity Urokinase products. The company’s professional
R&D team and advanced production equipment ensure continuous product
optimization and quality stability. With its excellent product quality and
efficient service, Kangyuan has become a preferred partner for many medical
institutions and distributors in global emerging markets.
With the continuous expansion of the global thrombolytic drug market, the
value of high-quality Urokinase will become increasingly prominent. Choosing a
reliable Urokinase manufacturer is the foundation for medical institutions to
improve treatment levels and for distributors to expand market share. Kangyuan
is dedicated to supporting the global cardiovascular healthcare industry with
premium Urokinase products and professional services. Whether you need stable
product supply, technical consultation or customized procurement solutions, our
team is ready to serve you. Feel free to contact Kangyuan for more details—we
will work with you to guard global cardiovascular health and create a better
future.